skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: The American Heart Journal remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial
Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial

Thiele, Holger, MD ; Desch, Steffen, MD ; Piek, Jan J., MD, PhD ; Stepinska, Janina, MD ; Oldroyd, Keith, MD ; Serpytis, Pranas, MD ; Montalescot, Gilles, MD ; Noc, Marko, MD ; Huber, Kurt, MD ; Fuernau, Georg, MD ; de Waha, Suzanne, MD ; Meyer-Saraei, Roza, PhD ; Schneider, Steffen, PhD ; Windecker, Stephan, MD ; Savonitto, Stefano, MD ; Briggs, Andrew, PhD ; Torremante, Patrizia ; Vrints, Christiaan, MD ; Schuler, Gerhard, MD ; Ceglarek, Uta, PhD ; Thiery, Joachim, MD ; Zeymer, Uwe, MD

The American heart journal, 2016-02, Vol.172, p.160-169 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Nicholls, Stephen J., MBBS, PhD ; Lincoff, A. Michael, MD ; Barter, Philip J., MBBS, PhD ; Brewer, H. Bryan, MD ; Fox, Keith A.A., MBChB, F MedSci ; Gibson, C. Michael, MD ; Grainger, Christopher, MD ; Menon, Venugopal, MD ; Montalescot, Gilles, MD ; Rader, Daniel, MD ; Tall, Alan R., MBBS ; McErlean, Ellen, MSN ; Riesmeyer, Jeffrey, MD ; Vangerow, Burkhard, MD ; Ruotolo, Giacomo, MD, PhD ; Weerakkody, Govinda J., PhD ; Nissen, Steven E., MD

The American heart journal, 2015-12, Vol.170 (6), p.1061-1069 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)

Avezum, Alvaro ; Makdisse, Marcia ; Spencer, Frederick ; Gore, Joel M. ; Fox, Keith A.A. ; Montalescot, Gilles ; Eagle, Kim A ; White, Kami ; Mehta, Rajendra H. ; Knobel, Elias ; Philippe Collet, Jean

The American heart journal, 2005, Vol.149 (1), p.67-73 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
4
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study

Collet, Jean-Philippe, MD, PhD ; Cayla, Guillaume, MD ; Cuisset, Thomas, MD ; Elhadad, Simon, MD ; Rangé, Grégoire, MD ; Vicaut, Eric, MD, PhD ; Montalescot, Gilles, MD, PhD

The American heart journal, 2011, Vol.161 (1), p.5-12.e5 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
5
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Berger, Jeffrey S., MD, MS ; Bhatt, Deepak L., MD, MPH ; Steg, P. Gabriel, MD ; Steinhubl, Steven R., MD ; Montalescot, Gilles, MD, PhD ; Shao, Mingyuan, MS ; Hacke, Werner, MD ; Fox, Keith A., MBChB ; Berger, Peter B., MD ; Topol, Eric J., MD ; Lincoff, A. Michael, MD

The American heart journal, 2011-07, Vol.162 (1), p.98-105.e1 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
6
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study
Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study

Montalescot, Gilles, MD, PhD ; Lassen, Jens Flensted, MD, PhD ; Hamm, Christian W., MD, PhD ; Lapostolle, Frédéric, MD ; Silvain, Johanne, MD, PhD ; ten Berg, Jurriën M., MD, PhD ; Cantor, Warren J., MD ; Goodman, Shaun G., MD, MSc ; Licour, Muriel, MSc ; Tsatsaris, Anne, MD ; van't Hof, Arnoud W., MD, PhD

The American heart journal, 2013-04, Vol.165 (4), p.515-522 [Periódico revisado por pares]

United States: Mosby, Inc

Texto completo disponível

Citações Citado por
7
Renal function, atherothrombosis extent, and outcomes in high-risk patients
Renal function, atherothrombosis extent, and outcomes in high-risk patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Renal function, atherothrombosis extent, and outcomes in high-risk patients

Dumaine, Raphaelle L., MD ; Montalescot, Gilles, MD, PhD ; Steg, Ph. Gabriel, MD ; Ohman, E. Magnus, MD ; Eagle, Kim, MD ; Bhatt, Deepak L., MD, MPH

The American heart journal, 2009-07, Vol.158 (1), p.141-148.e1 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
8
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study
Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study

Dudek, Dariusz, MD, PhD ; Dziewierz, Artur, MD ; Widimsky, Petr, MD, DrSc ; Bolognese, Leonardo, MD ; Goldstein, Patrick, MD ; Hamm, Christian, MD ; Tanguay, Jean-Francois, MD ; LeNarz, LeRoy, MD ; Miller, Debra L., RN, RCIS ; Brown, Eileen, PhD ; ten Berg, Jurrien, MD, PhD ; Montalescot, Gilles, MD, PhD

The American heart journal, 2015-11, Vol.170 (5), p.1025-1032.e2 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease
Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease

Steinberg, Benjamin A., MD ; Bhatt, Deepak L., MD ; Mehta, Shamir, MD ; Poole-Wilson, Philip A., MD ; O'Hagan, Philip, BSc ; Montalescot, Gilles, MD, PhD ; Ballantyne, Christie M., MD ; Cannon, Christopher P., MD

The American heart journal, 2008-10, Vol.156 (4), p.719-727 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
10
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial

Beygui, Farzin, MD, PhD ; Vicaut, Eric, MD, PhD ; Ecollan, Patrick, MD ; Machecourt, Jacques, MD, PhD ; Van Belle, Eric, MD, PhD ; Zannad, Faiez, MD, PhD ; Montalescot, Gilles, MD, PhD

The American heart journal, 2010-10, Vol.160 (4), p.642-648.e1 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.